SciVision Biotech Posts Strong Q2 2024 Results
SciVision Biotech reports a 33% net income increase in Q2 2024, EPS rises to NT$1.00 boosting investor confidence.
- Latest
- Trending
SciVision Biotech reports a 33% net income increase in Q2 2024, EPS rises to NT$1.00 boosting investor confidence.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.